PhenoPath, PLLC is a physician-owned specialty pathology practice and reference laboratory providing diagnostic and contract research services to pathology and oncology practices, hospitals, biopharmaceutical companies and research institutions in the U.S., Canada and around the world.
PhenoPath’s test menu includes a broad array of state-of-the-art immunohistochemistry, flow cytometry, fluorescence in situ hybridization and molecular assays as well as chromosome analysis.
New Tests and Panels / Tests Under Development / Specimen Requirement Changes
Read More »
2013 Updated ASCO-CAP HER2 Testing Guidelines in Breast Cancer/PhenoPath at the USCAP/Three Robust Antibodies in Classification of...Read More »
PhenoPath is one of the first labs in the US to adopt all the complex changes of the 2013 American...Read More »